Lataa...
Adjuvant chemotherapy in patients with completely resected non-small cell lung cancer
Adjuvant chemotherapy has been established as a standard for patients with completely resected non-small cell lung cancer (NSCLC). Adjuvant chemotherapy increased the 5-year survival rates by 4% to 15% within randomized trials and, based on a meta-analysis of five cisplatin-based trials, by 5.4%. Ad...
Tallennettuna:
| Julkaisussa: | Transl Lung Cancer Res |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Pioneer Bioscience Publishing Company
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4367797/ https://ncbi.nlm.nih.gov/pubmed/25806316 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2014.09.13 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|